Clinical Trials Browser

Interventional × Recurrence × LY2510924 × Clear all

NCT02652871 2019-11-15

LY2510924, Idarubicin and Cytarabine in Patients With Relapsed or Refractory Acute Myeloid Leukemia

Phase 1 Completed

Other hematologic neoplasm

Leukemia, Recurrence, Leukemia, Myeloid, Acute